Skip to main content
. 2021 Nov 28;25(1):30. doi: 10.3892/mmr.2021.12546

Figure 2.

Figure 2.

miR-671-5p inhibits the proliferation, migration and invasion in non-small cell lung cancer cells. (A) miR-671-5p expression levels in 95D or A549 cells transfected with miR-671-5p mimics or miR-NC were examined by RT-qPCR. (B) Cell proliferative ability was compared between miR-671-5p mimics- and miR-NC-transfected 95D or A549 cells by the CCK-8 assay. (C) Cell migration analysis was performed in 95D or A549 cells transfected with miR-671-5p mimics or miR-NC. (D and E) Transwell invasion assay was performed in 95D and A549 cells transfected with miR-671-5p mimics or miR-NC. (F) miR-671-5p expression levels in H1299 cells transfected with the miR-671-5p inhibitor or inhibitor NC were examined by RT-qPCR. (G) Cell proliferative ability was compared between miR-671-5p inhibitor- and inhibitor NC-transfected H1299 cells by the CCK-8 assay. (H) Cell migration and (I) Transwell invasion assays were performed in H1299 cells transfected with miR-671-5p inhibitor and inhibitor NC. All experiments were performed in triplicate. **P<0.01 and ***P<0.001 vs. miR-NC or inhibitor NC. miR, microRNA; NC, negative control; RT-qPCR, reverse transcription-quantitative PCR; CCK-8, Cell Counting Kit-8; OD, optical density.